Navigation Links
Springer adds Advances in Therapy to journals portfolio
Date:10/31/2007

As part of its continued commitment to providing high-quality information to professionals in the pharmaceutical industry, Springer has acquired the prestigious journal Advances in Therapy, to be published from 2008. With this move, Springer further enhances its services for clients in the pharmaceutical, healthcare and biotechnology industries.

Advances in Therapy, to be published by Springer Healthcare Communications (SHC), will continue to publish original research from the academic and research community across the globe as well as drug reviews and commissioned articles. Now in its 24th year of publication, the journal is Medline Indexed and has a strong Impact Factor, listed in both the ISI subject categories Pharmacology and Pharmacy and Medicine, Research and Experimental. The first issue of Advances in Therapy published by SHC will be Volume 25, No. 1, 2008.

The key feature of Advances in Therapy is the rapid publication of original research. Continuing this practice, SHC will increase its already rapid publication times to ensure online availability through SpringerLink within six weeks of submission. From 2008, Advances in Therapy will double its publication frequency from bimonthly to monthly.

Stephen Entwistle, Vice President of SHC, said, Advances in Therapy works closely with pharmaceutical researchers to deliver clinically important results to the academic and industrial community. I am very proud that the journal is now part of the Springer family and I am confident that the journals inclusion on SpringerLink will speed dissemination of important research worldwide.


'/>"/>
Contact: Renate Bayaz
renate.bayaz@springer.com
49-622-148-78531
Springer
Source:Eurekalert

Page: 1

Related medicine news :

1. Springer slated to spring a journal on Brain Imaging and Behavior
2. Advances in Treatment of Cataracts
3. Advances In Stem Cells Research
4. Speedier Access To Advances In Breast Cancer Sought For Patients
5. New Screening Techniques to Lead Advances In Pain Therapy
6. Advances Have Cut Combat Deaths in Iraq and Afghanistan
7. Prematurity More Accurately Predicted by Advances in Proteomic Technology
8. New DNA Tests Advances Treatment of Lysosomal Storage Diseases
9. Significant Advances in VCJD Prion Detection
10. Cancer Doctors Okays Controversial Prostate Therapy
11. Consensus on "Combination Therapy" for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... Researchers can ... so routine. A fresh look at this technique may yield big benefits. Scientists ... reproducibility of experiments in a cell culture laboratory—and lessen the risk of contamination ...
(Date:5/23/2016)... ... May 23, 2016 , ... In light of ... reminds pet owners that intervening at the first sign of their pet overheating ... normal body mechanisms cannot keep the body’s temperature within a safe range. Considered ...
(Date:5/23/2016)... ... May 23, 2016 , ... The Society for Women’s Health ... to move on from that role. , “No one in Washington led the way ... said SWHR Founder Florence Haseltine, MD, PhD. “We offer our deep gratitude to Phyllis ...
(Date:5/23/2016)... ... 2016 , ... Hadley Institute for the Blind and Visually ... or visually impaired, announces the election of Julie S. Tye as its next ... of Trustees retained Morris & Berger, a firm specializing in non-profit executive searches, ...
(Date:5/23/2016)... NY (PRWEB) , ... May 23, 2016 , ... ... the company’s top management team to meet the needs of its recent and ... to drive continued growth and business development across widening market segments. Max joined ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 23, 2016 Gamida Cell, a ... of cancer and orphan genetic diseases, announced today it ... million from the Israel Innovation Authority (formerly the Office ... Economy and Industry. The mission of the Israel Innovation ... industries, including science and technology, while stimulating economic growth. ...
(Date:5/22/2016)... 2016 DS Biopharma (DS) ... anti-inflammatory compound DS102 in chronic obstructive pulmonary disease ... (NASH) patients. Recent DS preclinical data ... tissue and has bronchodilatory, anti-inflammatory and anti-fibrotic properties ... Company will publish further detail on these findings ...
(Date:5/20/2016)... 2016 - Revenue Forecasts ... Growth Hormones, Recombinant Coagulation Factors and Regenerative Medicine ... New Study Reveals Selling Opportunities and Revenue Prospects ... ,What is the future of biologics, especially new ... commercial analysis. Staying ahead in data and knowledge, ...
Breaking Medicine Technology: